> top > docs > PMC:7650537 > spans > 27646-29621 > annotations

PMC:7650537 / 27646-29621 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T165 101-107 Body_part denotes Carina http://purl.org/sig/ont/fma/fma7465
T166 464-467 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T167 474-482 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T168 790-793 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T136 203-212 Disease denotes Infection http://purl.obolibrary.org/obo/MONDO_0005550
T137 453-461 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T138 779-787 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T139 813-821 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T216 410-412 http://purl.obolibrary.org/obo/CLO_0050050 denotes s1
T217 420-422 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1
T218 483-488 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T219 497-499 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1
T220 551-555 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T221 623-625 http://purl.obolibrary.org/obo/CLO_0008922 denotes S2
T222 623-625 http://purl.obolibrary.org/obo/CLO_0050052 denotes S2
T223 677-681 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T224 717-722 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T225 901-906 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T226 1540-1544 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T227 1684-1691 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T228 1913-1914 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T89 623-625 Chemical denotes S2 http://purl.obolibrary.org/obo/CHEBI_29387
T90 755-757 Chemical denotes S3 http://purl.obolibrary.org/obo/CHEBI_29388
T91 841-843 Chemical denotes S4 http://purl.obolibrary.org/obo/CHEBI_29401
T92 1039-1045 Chemical denotes formal http://purl.obolibrary.org/obo/CHEBI_48341
T93 1434-1440 Chemical denotes Access http://purl.obolibrary.org/obo/CHEBI_34922

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T17 755-770 http://purl.obolibrary.org/obo/GO_0072020 denotes S3: Development

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T213 0-15 Sentence denotes Acknowledgments
T214 16-223 Sentence denotes The authors deeply acknowledge the excellent technical assistance of Sina Müller and Carina Bäumler (both Labor Krause und Kollegen MVZ GmbH), as well as of Andrea Hölzgen (Institute for Infection Medicine).
T215 224-305 Sentence denotes Furthermore, we would like to thank all patients for participating in this study.
T216 307-330 Sentence denotes Supplementary Materials
T217 331-413 Sentence denotes The following are available online at https://www.mdpi.com/2076-2607/8/10/1572/s1.
T218 414-423 Sentence denotes Table S1:
T219 424-489 Sentence denotes Characteristics of the eight SARS-CoV-2 IgG/total antibody tests.
T220 490-500 Sentence denotes Figure S1:
T221 501-615 Sentence denotes Raw data from the plaque reduction neutralization test used as reference # 2 in the validation part of this study.
T222 616-626 Sentence denotes Figure S2:
T223 627-747 Sentence denotes Raw data from the plaque reduction neutralization test to investigate the kinetics of the virus-neutralizing antibodies.
T224 748-758 Sentence denotes Figure S3:
T225 759-833 Sentence denotes Development of high SARS-CoV-2 IgG avidities in three SARS-CoV-2 patients.
T226 834-844 Sentence denotes Figure S4:
T227 845-907 Sentence denotes Agreement of titers from two independent neutralization tests.
T228 908-944 Sentence denotes Click here for additional data file.
T229 946-966 Sentence denotes Author Contributions
T230 967-1275 Sentence denotes Conceptualization, A.K.; methodology, A.S., R.R., O.G., F.N., and A.K.; formal analysis, H.F. and A.K.; investigation, A.S., R.R., O.G., F.N., and A.K.; resources, H.F., T.L., and A.K.; writing—original draft preparation, A.K.; writing—review and editing, H.F. and A.K.; and supervision, H.F., T.L., and A.K.
T231 1276-1352 Sentence denotes All authors have read and agreed to the published version of the manuscript.
T232 1354-1361 Sentence denotes Funding
T233 1362-1453 Sentence denotes We acknowledge financial support by DFG within the funding program Open Access Publizieren.
T234 1455-1476 Sentence denotes Conflicts of Interest
T235 1477-1610 Sentence denotes Mikrogen, Viramed, and Virion-Serion companies kindly provided test kits free of charge, as well as technical support for this study.
T236 1611-1821 Sentence denotes These companies had no influence on the study design, the collection and testing of the samples, the interpretation of the results, or on the writing of the manuscript or in the decision to publish the results.
T237 1822-1929 Sentence denotes Some of the data of the assay validation part of this study have already been published as a preprint [33].
T238 1930-1975 Sentence denotes All authors declare no conflicts of interest.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
484 813-823 Species denotes SARS-CoV-2 Tax:2697049
485 824-832 Species denotes patients Tax:9606
486 453-463 Species denotes SARS-CoV-2 Tax:2697049
487 779-789 Species denotes SARS-CoV-2 Tax:2697049
492 1106-1107 Gene denotes N Gene:43740575
493 1025-1026 Gene denotes N Gene:43740575
494 1088-1089 Gene denotes S Gene:43740568
495 1007-1008 Gene denotes S Gene:43740568
497 1398-1401 Chemical denotes DFG